Journal article
Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
Current drug metabolism, Vol.18(9), pp.1173-1185
03/01/2012
DOI: 10.2174/138920012799362873
PMID: 22316156
Abstract
Due to their role in cellular signaling mitogen activated protein (MAP) kinases represent targets of pharmaceutical interest. However, the majority of known MAP kinase inhibitors compete with cellular ATP and target an ATP binding pocket that is highly conserved in the 500 plus representatives of the human protein kinase family. Here we review progress toward the development of non-ATP competitive MAP kinase inhibitors for the extracellular signal regulated kinases (ERK1/2), the c-jun N-terminal kinases (JNK1/2/3) and the p38 MAPKs (α, β, γ, and δ). Special emphasis is placed on the role of computational methods in the drug discovery process for MAP kinases. Topics include recent advances in X-ray crystallography theory that improve the MAP kinase structures essential to structurebased drug discovery, the use of molecular dynamics to understand the conformational heterogeneity of the activation loop and inhibitors discovered by virtual screening. The impact of an advanced polarizable force field such as AMOEBA used in conjunction with sophisticated kinetic and thermodynamic simulation methods is also discussed.
Details
- Title: Subtitle
- Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
- Creators
- Michael J SchniedersTamer S KaoudChunli YanKevin N DalbyPengyu Ren
- Resource Type
- Journal article
- Publication Details
- Current drug metabolism, Vol.18(9), pp.1173-1185
- DOI
- 10.2174/138920012799362873
- PMID
- 22316156
- ISSN
- 1389-2002
- Language
- English
- Date published
- 03/01/2012
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Biochemistry and Molecular Biology; Chemical and Biochemical Engineering
- Record Identifier
- 9984024524002771
Metrics
14 Record Views